Discriminating subtypes in advanced breast cancer with ctDNA methylation profiling

被引：0
|
作者：
Pasha, Nida
Cutts, Ros
Amenssag, Aya
Hrebien, Sarah
Gulati, Aditi
Gao, Qiong
Haider, Syed
Roylance, Rebecca
Tutt, Andrew N. J.
Baird, Richard D.
MacPherson, Iain R.
Ring, Alistair E.
Johnston, Stephen R. D.
Okines, Alicia Frances Clare
Garcia-Murillas, Isaac
Filippi, Sarah
Turner, Nicholas C.
机构：
[1] Inst Canc Res, London, England
[2] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England
[3] Univ Coll London Hosp NHS Fdn Trust, London, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[5] Beatson Canc Ctr, Glasgow, Lanark, Scotland
[6] Royal Marsden NHS Fdn Trust, Surrey, England
[7] Royal Marsden NHS Fdn Trust, London, England
[8] Imperial Coll London, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1013
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes
    Gyorffy, B.
    Bottai, G.
    Fleischer, T.
    Munkacsy, G.
    Paladini, L.
    Bressen-Dale, A. L.
    Kristensen, V.
    Santarpia, L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S41 - S41
  • [42] Aberrant promoter methylation profiling of breast cancer using quantitative methylation-specific PCR
    Monteiro, P
    Jerónimo, C
    Henrique, R
    Carvalho, AL
    Hoque, MO
    Paris, I
    Leal, C
    Lopes, C
    Teixeira, MR
    Sidransky, D
    MODERN PATHOLOGY, 2005, 18 : 44A - 45A
  • [43] Analysis of ctDNA in advanced breast cancer reveals polyclonal disease associated with adverse outcome
    Kingston, B.
    Cutts, R.
    Beaney, M.
    Walsh-Crestani, G.
    Hrebien, S.
    Kilburn, L.
    Kernaghan, S.
    Moretti, L.
    Wilkinson, K.
    MacPherson, I.
    Baird, R. D.
    Roylance, R.
    Reis-Filho, J. S.
    Hubank, M.
    Faull, I.
    Banks, K.
    Garcia-Murillas, I.
    Bliss, J.
    Ring, A.
    Turner, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S65 - S66
  • [44] Prevalence of gene rearrangement on ctDNA NGS and its targetability in patients with advanced breast cancer
    Bahl, A.
    Bharat, R.
    Jain, S. S.
    Joshi, N.
    Rohatgi, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S396 - S396
  • [45] Correlation between ctDNA methylation and CEA in colorectal cancer
    Tang, W-W.
    An, H-X.
    Zhou, D.
    Cai, M-Q.
    Zeng, R.
    Lv, X-J.
    Chen, L-L.
    Ye, F.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC/MS approach
    Wojakowska, Anna
    Chekan, Mykola
    Marczak, Lukasz
    Polanski, Krzysztof
    Lange, Dariusz
    Pietrowska, Monika
    Widlak, Piotr
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 417 (0C) : 149 - 157
  • [47] Transcriptomic and microRNA profiling revealed novel therapeutic targets for breast cancer subtypes
    Elango, Ramesh
    Vishnubalaji, Radhakrishnan
    Rashid, Sameera
    Alajez, Nehad
    CANCER RESEARCH, 2024, 84 (03)
  • [48] The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Stamatovic, Ljiljana
    Susnjar, Snezana
    Gavrilovic, Dusica
    Minic, Ivana
    Ursulovic, Tamara
    Dzodic, Radan
    JOURNAL OF BUON, 2018, 23 (05): : 1273 - 1280
  • [49] The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Susnjar, S.
    Stamatovic, L.
    Gavrilovic, D.
    Minic, I.
    Ursulovic, T.
    BREAST, 2017, 32 : S81 - S82
  • [50] PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
    Jorgensen, Charlotte L. T.
    Nielsen, Torsten O.
    Bjerre, Karsten D.
    Liu, Shuzhen
    Wallden, Brett
    Balslev, Eva
    Nielsen, Dorte L.
    Ejlertsen, Bent
    ACTA ONCOLOGICA, 2014, 53 (06) : 776 - 787
12345